2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
CA 2335809 A1 · Owner: Glaxo Group Limited · Inventors: Hobbs, Heather; Keeling, Suzanne Elaine; Allen, David George
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
There are provided according to the invention novel compounds of formula (I) , wherein R1 R2 and R3 are as defined in the specification processes for , preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 23, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 23, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 23, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.